One in Six Billion
A podcast about diabetes and genes hosted by Andrew Hattersley and Maggie Shepherd.
One in Six Billion
Series 4 episode 6: Hannah Robinson and Nick Thomas. Taking immunotherapy to delay adult-onset Type 1 diabetes
•
Andrew Hattersley and Maggie Shepherd
•
Season 4
•
Episode 6
Hannah Robinson was the first adult in the UK to be given the new immunotherapy drug Teplizumab, which aims to slow down the development of type 1 diabetes. Hannah had multiple pancreatic autoantibodies and hence is on the path to developing Type 1 diabetes (Series 4 Episode 3). Her consultant, Nick Thomas, arranged 14 consecutive daily hospital visits for her to receive the drug through a drip.